2seventy bio, Inc. (TSVT) Stock Analysis
DELISTED 2025
What happened to 2seventy bio, Inc. (TSVT) stock?
2seventy bio, Inc. (TSVT) no longer trades on public markets. It was delisted in May 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- May 2025
- Last recorded price (historical):
- $5.00 (last quote on record before the May 2025 delisting; historical, not a current quote)
Market cap $266M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
2seventy bio, Inc. (TSVT). 2seventy bio, Inc. is a biotechnology firm specializing in the discovery, development, and commercialization of cell and gene therapies for cancer, with a primary focus on CAR-T cell therapeutics for multiple myeloma.
Last analyzed: Jun 15, 20262seventy bio, Inc. (TSVT) Healthcare & Pipeline Overview
More about this archive record
Can I still buy TSVT shares?
No. TSVT stopped trading on public markets in May 2025, so the shares are not available through a broker. Anything you see quoted for TSVT elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before TSVT stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to 2seventy bio, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.